Home > Qtrly Results > MARKSANS PHARMA

MARKSANS PHARMA
Quarterly Results Analysis [Sep2024]

MARKSANS PHARMA is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for MARKSANS PHARMA
Please provide your vote to see the results

MARKSANS PHARMA Quarterly Results

Consolidated Sep2024
UnAudited
Jun2024
UnAudited
Mar2024
UnAudited
Dec2023
UnAudited
Sep2023
UnAudited
Jun2023
UnAudited
Mar2023
Audited
Dec2022
UnAudited
Revenues ₹642 Cr ₹591 Cr ₹560 Cr ₹586 Cr ₹531 Cr ₹500 Cr ₹486 Cr ₹480 Cr
Expenses ₹506 Cr ₹462 Cr ₹450 Cr ₹453 Cr ₹417 Cr ₹398 Cr ₹376 Cr ₹403 Cr
Operating Income ₹136 Cr ₹128 Cr ₹110 Cr ₹133 Cr ₹114 Cr ₹102 Cr ₹110 Cr ₹77 Cr
Other Income ₹11 Cr ₹15 Cr ₹17 Cr ₹5 Cr ₹19 Cr ₹10 Cr ₹11 Cr ₹18 Cr
Interest ₹3 Cr ₹3 Cr ₹5 Cr ₹3 Cr ₹2 Cr ₹2 Cr ₹2 Cr ₹2 Cr
Depreciation ₹20 Cr ₹20 Cr ₹21 Cr ₹22 Cr ₹18 Cr ₹14 Cr ₹14 Cr ₹13 Cr
Profit Before Tax ₹125 Cr ₹120 Cr ₹100 Cr ₹113 Cr ₹114 Cr ₹97 Cr ₹104 Cr ₹79 Cr
Profit After Tax ₹98 Cr ₹89 Cr ₹78 Cr ₹83 Cr ₹84 Cr ₹70 Cr ₹83 Cr ₹62 Cr
EPS ₹2.13 ₹1.96 ₹1.73 ₹1.84 ₹1.84 ₹1.52 ₹1.81 ₹1.57
Industry Peers & Returns1W1M1Y
MARKSANS PHARMA 1.5% -14.7% 89.4%
SUN PHARMACEUTICAL INDUSTRIES 0.9% 4.4% 50%
CIPLA 2.1% 0.2% 22.8%
DR REDDYS LABORATORIES -1.1% 12.1% 18.1%
ZYDUS LIFESCIENCES 1.8% 0.9% 41.3%
DIVIS LABORATORIES 4.6% -1.1% 55.6%
MANKIND PHARMA 0.9% 13.3% 45.6%
TORRENT PHARMACEUTICALS 1.2% 2.5% 48.2%
LUPIN 7.6% 15.1% 78.8%

MARKSANS PHARMA Quarterly Revenues

Revenues
Q-o-Q

8.69 %

Y-o-Y

20.84 %

Quarters Revenues % Change
Sep2024 ₹642 Cr
8.69
Jun2024 ₹591 Cr
5.47
Mar2024 ₹560 Cr
-4.46
Dec2023 ₹586 Cr
10.33
Sep2023 ₹531 Cr
6.24
Jun2023 ₹500 Cr
2.89
Mar2023 ₹486 Cr
1.28
Dec2022 ₹480 Cr -

MARKSANS PHARMA Quarterly Operating Profit

Operating Profit
Q-o-Q

5.64 %

Y-o-Y

19.07 %

Quarters Operating Profit % Change
Sep2024 ₹136 Cr
5.64
Jun2024 ₹128 Cr
17.14
Mar2024 ₹110 Cr
-17.58
Dec2023 ₹133 Cr
16.74
Sep2023 ₹114 Cr
11.75
Jun2023 ₹102 Cr
-6.92
Mar2023 ₹110 Cr
42.93
Dec2022 ₹77 Cr -
Operating Margins
Q-o-Q

-2.80 %

Y-o-Y

-1.45 %

Quarters Operating Margin% % Change
Sep2024 21.14%
-2.80
Jun2024 21.75%
11.08
Mar2024 19.58%
-13.74
Dec2023 22.7%
5.83
Sep2023 21.45%
5.20
Jun2023 20.39%
-9.54
Mar2023 22.54%
41.14
Dec2022 15.97% -

MARKSANS PHARMA Quarterly Profit After Tax

Profit After Tax(PAT)
Q-o-Q

9.76 %

Y-o-Y

16.59 %

Quarters Profit After Tax % Change
Sep2024 ₹98 Cr
9.76
Jun2024 ₹89 Cr
14.71
Mar2024 ₹78 Cr
-6.41
Dec2023 ₹83 Cr
-1.06
Sep2023 ₹84 Cr
19.04
Jun2023 ₹70 Cr
-14.84
Mar2023 ₹83 Cr
32.75
Dec2022 ₹62 Cr -
PAT Margins
Q-o-Q

0.99 %

Y-o-Y

-3.49 %

Quarters PAT Margin(%) % Change
Sep2024 15.23 %
0.99
Jun2024 15.08 %
8.80
Mar2024 13.86 %
-2.05
Dec2023 14.15 %
-10.33
Sep2023 15.78 %
11.99
Jun2023 14.09 %
-17.22
Mar2023 17.02 %
31.02
Dec2022 12.99 % -

MARKSANS PHARMA Quarterly Earnings Per Share (EPS)

EPS
Q-o-Q

8.67 %

Y-o-Y

15.76 %

Quarters EPS % Change
Sep2024 ₹2.13
8.67
Jun2024 ₹1.96
13.29
Mar2024 ₹1.73
-5.98
Dec2023 ₹1.84
0.00
Sep2023 ₹1.84
21.05
Jun2023 ₹1.52
-16.02
Mar2023 ₹1.81
15.29
Dec2022 ₹1.57 -

You may also like the below Video Courses